Palantir (PLTR) stock fell 2% Friday morning and was set to post a 5% decline for the trading week amid continued concerns about the company's lofty valuation. Shares of Palantir fell 12% Tuesday, shaving just over $35 billion from the AI tech firm’s market capitalization after the company’s first quarter earnings report showed international sales dropping and raised questions over whether the war tech firm is overvalued. Then, the stock rose 1.5% Wednesday and another 7.8% Thursday as stocks across the board rose on the Trump administration’s announcement of a US-UK trade deal. NasdaqGS - Nasdaq Real Time Price•USD (PLTR) Follow View Quote Details 117.11 - (-1.71%) As of 11:30:34 AM EDT. Market Open. Advanced Chart Read more about today's stock moves and market action. Those gains added roughly $24 billion back to the tech firm’s market cap, which stood at $281 billion as of Thursday’s close. That figure was $293 billion at the end of the prior trading week. Palantir’s data analytics and AI software is used by businesses, militaries, government agencies, and police departments alike — to the chagrin of human rights advocates and even some investors and former employees — to do everything from surveillance and war planning to supply chain management. As part of its commercial business, Palantir’s software is used by medical providers like Mount Sinai and the Cleveland Clinic, financial powerhouses such as Citi (C), oil companies such as BP (BP), and automakers such as Stellantis (STLA). Sell-side analysts at RBC Capital Markets and Jefferies have pointed to Palantir’s high valuation — 80 times its expected revenue in 2025 — as a risk for investors, and they see shares falling to $40 and $60, respectively. Jefferies' Brent Thill called Palantir’s current value “irrational.” Palantir shares have risen more than 455% over the past year, benefiting more than other stocks in the AI trade from the boom in artificial intelligence. But DA Davidson analyst Gil Luria, who holds a Neutral rating on the stock, told Yahoo Finance in an email Friday that “as long as it continues to perform on a fundamental basis, there is little reason to think that will stop.” “No other technology company is growing this fast, at this scale, with these margins,” Luria said. “Having said that, valuations this high rarely stay this high for very long,” he added. “There are a few things that could happen that would compress this valuation — competitors figuring out the formula, a weak quarter, or a disruption to US federal spending.” “The high valuation also inherently makes shares more volatile — small changes to the outlook or sentiment can translate to large swings in the stock price.” Story Continues Logo of Palantir Technologies Inc. (Photo illustration by Cheng Xin/Getty Images)·Cheng Xin via Getty Images William Blair analyst Louie DiPalma echoed that sentiment in a note to investors earlier this week: “Shares may continue to trade higher on new government contract wins and robust U.S. commercial adoption.” Palantir was recently awarded a controversial $30 million contract with ICE to surveil immigrants in the US. Palantir was also awarded a $178 million contract by the US Army in March to develop AI military trucks. However, DiPalma said that “Palantir’s revenue growth will likely decelerate in the second half of 2025 and early 2026 due to competitive forces.” Palantir said in its earnings report Monday that first quarter revenue in its international commercial segment, which sells software to businesses abroad, posted a 5% decline in the first quarter from the prior year due to "headwinds" in Europe. Since 2023, Palantir executives have noted difficulties in that market, as the region has been slower to make large-scale investments in AI, faces slowing GDP growth, and Europe looks to achieve “tech sovereignty” by shifting investments from American tech to homegrown firms. And Palantir’s recent “alignment with the Trump administration” — seen in its recent defense contracts to expand AI capabilities for the military and its ICE contract to surveil migrants — “may be an issue for some European buyers,” Luria told Yahoo Finance in an email earlier this week. “If the US is able to achieve similar deals with other European countries there may be an opportunity for Palantir to improve its continental Europe business," Luria told Yahoo Finance.StockStory aims to help individual investors beat the market. Laura Bratton is a reporter for Yahoo Finance. Follow her on Bluesky @laurabratton.bsky.social. Email her at [email protected]. Click here for the latest technology news that will impact the stock market Read the latest financial and business news from Yahoo Finance View Comments
Palantir stock set to end the week down amid investor concerns over lofty valuation
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...